MetLife, Inc. vs JP Morgan Chase & Co. — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
7.4
Buy
Quality
Health
Growth
Valuation
Sentiment
MET
67% of 18 covering analysts rate it Buy or Strong Buy.
⚠ negative free cash flow.
JPM
High-quality business with 16% return on equity and 34% profit margins.
Analyst Consensus
BUY
Target $89.06 (+10.9%)
16 analysts
HOLD
Target $340.45 (+8.9%)
22 analysts
Fundamentals
MET
JPM
17.0×
Trailing P/E
15.0×
7.3×
Forward P/E
13.3×
4.4%
Profit Margin
33.9%
23.4%
Gross Margin
0.0%
12.0%
ROE
16.5%
27.6%
Revenue Growth
12.7%
-34.2%
Earnings Growth
17.2%
0.73
Beta
1.04
—
Price / Book
—
$52.4B
Market Cap
$837.8B
$67 – $84
52-Week Range
$242 – $337
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.